Article
Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.
Neuromuscular disorders : NMD - 1 Jan 2010
Jungbluth Heinz, Cullup Tom, Lillis Suzanne, Zhou Haiyan, Abbs Stephen, Sewry Caroline, Muntoni Francesco
Abstract excerpt
Dynamin 2 (DNM2)-related dominant centronuclear myopathy is usually a mild disorder, but more severe variants have been associated with mutations affecting the pleckstrin homology (PH) domain of the protein, mainly implicated in different forms of Charcot-Marie-Tooth Disease (CMT). Whilst DNM2-related CMT may feature non-neurological findings including cataracts, this has not been reported in DNM2-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
